These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance and management of drug-related QT interval prolongation. Crouch MA; Limon L; Cassano AT Pharmacotherapy; 2003 Jul; 23(7):881-908. PubMed ID: 12885102 [TBL] [Abstract][Full Text] [Related]
8. Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation. Baracaldo-Santamaría D; Llinás-Caballero K; Corso-Ramirez JM; Restrepo CM; Dominguez-Dominguez CA; Fonseca-Mendoza DJ; Calderon-Ospina CA Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360853 [TBL] [Abstract][Full Text] [Related]
9. Drug-induced QT prolongation and sudden death. Del Rosario ME; Weachter R; Flaker GC Mo Med; 2010; 107(1):53-8. PubMed ID: 20222297 [TBL] [Abstract][Full Text] [Related]
10. Drug induced QT prolongation and torsades de pointes. Yap YG; Camm AJ Heart; 2003 Nov; 89(11):1363-72. PubMed ID: 14594906 [No Abstract] [Full Text] [Related]
11. Drug-induced QT Interval Prolongation in the Intensive Care Unit. Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523 [TBL] [Abstract][Full Text] [Related]
12. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation? Hondeghem LM Drug Saf; 2018 Jan; 41(1):11-17. PubMed ID: 28853038 [TBL] [Abstract][Full Text] [Related]
13. Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone. Atar S; Freedberg NA; Antonelli D; Rosenfeld T Pacing Clin Electrophysiol; 2003 Mar; 26(3):785-6. PubMed ID: 12698686 [TBL] [Abstract][Full Text] [Related]
14. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake. Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428 [TBL] [Abstract][Full Text] [Related]
15. QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator. Kaźmierczak J; Peregud-Pogorzelska M; Rzeuski R Pacing Clin Electrophysiol; 2007 Aug; 30(8):1043-6. PubMed ID: 17669094 [TBL] [Abstract][Full Text] [Related]
16. QT interval and drug therapy. Drug Ther Bull; 2016 Mar; 54(3):33-6. PubMed ID: 26966121 [TBL] [Abstract][Full Text] [Related]
17. Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP). Ritter JM Br J Clin Pharmacol; 2012 Mar; 73(3):331-4. PubMed ID: 22329611 [No Abstract] [Full Text] [Related]
18. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. Lin JC; Quasny HA Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570 [TBL] [Abstract][Full Text] [Related]
19. [QTc-prolonging drugs and the risk of sudden death]. Reingardiene D; Vilcinskaite J Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963 [TBL] [Abstract][Full Text] [Related]
20. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome. Johansson M; Carlsson L J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]